ACRS
ACRS
NASDAQ · Pharmaceuticals

Aclaris Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Pharmaceutical Stocks Healthcare Stocks
$5.50
+0.10 (+1.85%)
As of Sep 20, 10:29 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 16 89%
Hold 2 11%
Sell 0 0%
Price Target
Analyst Price Target +223.5% upside
Low Target $13.99
Average Target $17.79
High Target $22.90
Current Price $5.50
Current
$5.50
Target
$17.79
$13.99 $17.79 avg $22.90
Scenario Analysis
Bear Case
$13.99
154.4%
Low target
Base Case
$17.79
+223.5%
Avg target
Bull Case
$22.90
+316.4%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$6.60
-16.7% from high
52-Week Low
$1.74
+216.1% from low
50-Day SMA
$4.51
+22.0% vs SMA
RSI (14)
55.5
Neutral
Target vs 52W High
$17.79
+169.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +15.6%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
 Buy 36 72% $159.27 +7.6%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +20.3%
BMY
Bristol-Myers Squibb Co
 Hold 35 43% $174.50 +185.4%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -37.1%
ZTS
Zoetis Inc
 Hold 24 50% $209.87 +193.1%